11/6
04:22 pm
cntx
Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results [Yahoo! Finance]
Medium
Report
Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results [Yahoo! Finance]
11/6
04:06 pm
cntx
Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Medium
Report
Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results
10/23
07:30 am
cntx
Context Therapeutics to Participate in Upcoming Investor Conferences in November
Medium
Report
Context Therapeutics to Participate in Upcoming Investor Conferences in November
10/16
07:30 am
cntx
Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Medium
Report
Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
9/23
02:05 pm
cntx
Context Therapeutics Inc. (NASDAQ: CNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Context Therapeutics Inc. (NASDAQ: CNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
9/23
07:30 am
cntx
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
Medium
Report
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
9/16
09:09 am
cntx
We Think Context Therapeutics (NASDAQ:CNTX) Can Afford To Drive Business Growth [Yahoo! Finance]
Low
Report
We Think Context Therapeutics (NASDAQ:CNTX) Can Afford To Drive Business Growth [Yahoo! Finance]
9/16
08:03 am
cntx
Context Therapeutics Inc. (NASDAQ: CNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Context Therapeutics Inc. (NASDAQ: CNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
9/12
10:57 am
cntx
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year? [Yahoo! Finance]
9/4
07:30 am
cntx
Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors
Low
Report
Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors
8/27
11:17 am
cntx
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year? [Yahoo! Finance]